Competitive Enterprise Institute
Competitive Enterprise Institute
  • Facebook
  • Twitter
  • YouTube
  • Instagram
  • About
  • Policy
  • Products
  • Blog
  • Events
  • Subscribe
  • Donate
  • About
  • Policy
  • Products
  • Blog
  • Events
  • Subscribe
  • Donate

Sign up below to receive the latest research, news, and commentary from CEI experts.

Sign Up

About CEI

  • Press Room
  • Team
  • Careers
  • Internships
  • Our History
  • Julian L. Simon Award Winners
  • Research Independence
  • Prometheus Society
  • Ways to Support CEI

Request a policy briefing from a CEI expert.

Learn More

All Policy Areas

  • Capitalism
    • Antitrust
    • Subsidies and Bailouts
    • Capitalism and Free Enterprise
  • Deregulation
    • Banking and Finance
    • Consumer Freedom
    • Labor and Employment
    • Regulatory Reform
    • Trade and International
  • Energy and Environment
    • Chemical Risk
    • Climate
    • Energy
    • Lands and Wildlife
    • Water and Air Quality
  • Innovation
    • Healthcare
    • Tech and Telecom
    • Transportation
  • Law and Litigation
    • CEI Litigation
    • Free Speech
    • Government Transparency
    • Legal Studies
    • Property Rights
  • Housing
    • Environmental Housing Policy
    • Federal Housing Policy
    • Housing Finance Policy
    • State & Local Housing Policy
  • Government Affairs

Sign up below to receive the latest research, news, and commentary from CEI experts.

Sign Up

All Products

  • Research
    • Fast Track
    • Issue Analysis
    • OnPoint
    • Profiles in Capitalism
    • 10,000 Commandments
    • Agenda for Congress
    • Books
    • Individual Studies
  • Newsletters
    • CEI Planet
    • The Bulletin
    • The Surge
    • Great Capitalism
  • Outreach
    • Coalition Letters
    • Legal Briefs
    • Congressional Testimony
    • Regulatory Comments
  • Podcasts
    • Free the Economy
    • How The World Works

Sign up below to receive the latest research, news, and commentary from CEI experts.

Sign Up

All Events

  • Press Room
  • Team
  • Careers
  • Internships
  • Our History
  • Julian L. Simon Award Winners
  • Research Independence
  • Prometheus Society
  • Ways to Support CEI

Sign up below to receive the latest research, news, and commentary from CEI experts.

Join Us

Support CEI

  • Give Online
  • Wire Transfer
  • Estate Planning
  • Donate Crypto
  • Facebook
  • Twitter
  • YouTube
  • Instagram

Obamacare Will Spawn Crowded Waiting Rooms and Pointless Busywork for Doctors

  • Blog
  • Hans Bader • 10/20/2010
  • Healthcare

Health care costs will go up under Obamacare for many reasons, such as the wasteful red tape it imposes on health savings accounts (HSAs).  Max Borders explains how the new healthcare law is harming the HSA his family relies on.  He used to be able to pay for over-the-counter medicines cheaply using his HSA.  But Obamacare will require him to get a doctor’s prescription for the very same medicine, a pointless waste of time:

Under the new health care law, consumers using workplace pre-tax health savings accounts will soon need a doctor’s note to pay for Tylenol and an estimated 15,000 other over-the-counter drugs.  Starting Jan. 1, employees who use flexible spending accounts (FSAs), health saving accounts (HSAs), or health reimbursement arrangements (HRAs) to pay for common medications such as pain relievers, cold medicines, antacids and allergy medications will need prescriptions.”

In USA Today, “ObamaCare Will Clog America’s Medical System,” by Dr. Marc Siegel, explains how Obamacare will fuel wasteful medical spending and result in more crowded waiting rooms in doctor’s offices and emergency rooms, “driving up costs and premiums.”

Obamacare has already led to big premium increases, and the elimination of some high-quality health plans.  It also includes a $60 billion excise tax on health insurers that will be passed on to consumers, as well as taxes on medical devices needed by patients, and a future tax increase on investors that will go into effect in 2013.

News Release

FDA commissioner resignation opens opportunity for refocus on science over politics

  • Jeremy Nighohossian
  • 05/12/2026

After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring a…

Health and Safety

Blog

Don’t hinder biosimilar development

  • By: Jeremy Nighohossian
  • 04/30/2026

In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing. That…

Healthcare

Blog

The unseen costs of banning PBM-owned pharmacies in Tennessee

  • By: Hayden Stolzenberg
  • 04/23/2026

Tennessee lawmakers recently passed the FAIR Rx Act, which would bar companies from owning pharmacies while also operating a pharmacy benefit manager (PBM) and…

Healthcare

  • Home
  • About
  • Policy
  • News
  • Products
  • Events
  • Blog
  • Donate

Special Projects

  • Ten Thousand Commandments
  • Eye on FTC
  • Children Online Safety Tools
  • Net Neutrality 101
1310 L Street NW, 7th Floor Washington, DC 20005
Phone: 202-331-1010

Follow Us:

  • Facebook
  • Twitter
  • YouTube
  • Instagram
Competitive Enterprise Institute

©2026 Competitive Enterprise Institute | Privacy Policy